Order Article Reprints

Juárez A, Salas MQ, Pedraza A, Suárez-Lledó M, Rodríguez-Lobato LG, Solano MT, Serrahima A, Nomdedeu M, Cid J, Lozano M, et al. Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study. Cancers. 2024; 16(14):2567. https://doi.org/10.3390/cancers16142567

Juárez, Alex, María Queralt Salas, Alexandra Pedraza, María Suárez-Lledó, Luís Gerardo Rodríguez-Lobato, María Teresa Solano, Anna Serrahima, Meritxell Nomdedeu, Joan Cid, Miquel Lozano, and et al. 2024. "Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study" Cancers 16, no. 14: 2567. https://doi.org/10.3390/cancers16142567

Juárez, A., Salas, M. Q., Pedraza, A., Suárez-Lledó, M., Rodríguez-Lobato, L. G., Solano, M. T., Serrahima, A., Nomdedeu, M., Cid, J., Lozano, M., Charry, P., Arcarons, J., Llobet, N., Rosiñol, L., Fernández-Avilés, F., Rovira, M., & Martínez, C. (2024). Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study. Cancers, 16(14), 2567. https://doi.org/10.3390/cancers16142567